Initial Suppression of Transforming Growth Factor-β Signaling and Loss of TGFBI Causes Early Alveolar Structural Defects Resulting in Bronchopulmonary Dysplasia
Authors:
- 1 April 2016
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 186 (4) , 777-793
Abstract
No abstract availableKeywords
Funding Information
- Indiana University School of Medicine (K12 HD068371)
- NIH (R01 HL115619)
This publication has 82 references indexed in Scilit:
- Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung diseaseRespiratory Research, 2013
- Aberrant signaling pathways of the lung mesenchyme and their contributions to the pathogenesis of bronchopulmonary dysplasiaBirth Defects Research Part A: Clinical and Molecular Teratology, 2011
- Neonatal Hyperoxia Causes Pulmonary Vascular Disease and Shortens Life Span in Aging MiceThe American Journal of Pathology, 2011
- The new bronchopulmonary dysplasiaCurrent Opinion in Pediatrics, 2011
- Noncanonical TGF-β pathways, mTORC1 and Abl, in renal interstitial fibrogenesisAmerican Journal of Physiology-Renal Physiology, 2010
- Origin of Cardiac Fibroblasts and the Role of PeriostinCirculation Research, 2009
- Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activityAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- FGF signaling is required for myofibroblast differentiation during alveolar regenerationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissuesJournal of Cellular Biochemistry, 2007
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992